Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Surgery Partners (SGRY) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Surgery Partners (SGRY) over the last 12 years, with Q3 2025 value amounting to -$0.18.

  • Surgery Partners' EPS (Basic) rose 2800.0% to -$0.18 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.36, marking a year-over-year decrease of 18936.17%. This contributed to the annual value of $0.1 for FY2024, which is 21012.27% up from last year.
  • Surgery Partners' EPS (Basic) amounted to -$0.18 in Q3 2025, which was up 2800.0% from -$0.02 recorded in Q2 2025.
  • In the past 5 years, Surgery Partners' EPS (Basic) ranged from a high of $0.37 in Q4 2023 and a low of -$0.57 during Q1 2021
  • Moreover, its 5-year median value for EPS (Basic) was -$0.2 (2023), whereas its average is -$0.15.
  • Its EPS (Basic) has fluctuated over the past 5 years, first skyrocketed by 25490.7% in 2023, then tumbled by 52500.0% in 2024.
  • Quarter analysis of 5 years shows Surgery Partners' EPS (Basic) stood at $0.07 in 2021, then tumbled by 442.86% to -$0.24 in 2022, then soared by 254.91% to $0.37 in 2023, then plummeted by 199.38% to -$0.37 in 2024, then surged by 51.28% to -$0.18 in 2025.
  • Its EPS (Basic) was -$0.18 in Q3 2025, compared to -$0.02 in Q2 2025 and -$0.3 in Q1 2025.